 |
 |
 |
Czech Republic |
|
|
The Pharmaceutical Market: Czech Republic
Publication Date January 2007
Publisher Espicom
Product Type Strategic Report
Pages 84
ISBN Number not applicable
Product Code ESP751
|
|
|
Summary
The 1990s were a period of significant change for both the Czech nation and its healthcare sector. The government has decentralised the health sector through methods of rationalisation and large scale privatisation, and created a health system with a diverse mixture of establishments. The introduction of a health insurance scheme has also played an important part in the development of Czech healthcare.
The Czech pharmaceutical sector remains one of the better regional prospects for overseas suppliers, being relatively wealthy and largely reliant on imported medicines. The international pharmaceutical industry has continued to challenge the government over its dubious pricing and reimbursement criteria and IP protection remains an area that needs strengthening. However, much of the country's regulatory structure has been aligned with EU Directives and other amendments are expected in the near future. The Czech Republic attained full EU membership in May 2004.
These in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
|
Content
Background Data
- Geography
- Political Overview
- Economic Overview
- Population
- Population, 1995-2005
- Population by Age Group & Sex, 2005
- Demographic Indicators
- Principal Demographic Indicators, 1997-2005
- Mortality
- Causes of Death, 2005
- Causes of Death, 2001-2004
- Deaths due to Circulatory Disease, 2005
- Morbidity
- Infectious diseases
- Notified Infectious Diseases,
- Cancer
- New Cases of Cancer Reported in Males,
- New Cases of Cancer Reported in Females,
- Diabetes
- HIV/AIDS
- Charts
- Map of the Czech Republic
- Population by Age Group, 2005 (%)
- Leading Causes of Death, 2005 (%)
- Chichester, West Sussex, PO20 2FS, United Kingdom
Healthcare System
- Organisation & Administration
- Health Expenditure
- Public/Private Health Expenditure, 1997-2005
- Hospital Services
- Hospital Resources
- Healthcare Facilities and Beds, 2005
- Healthcare Facilities and Beds, 2003-2004
- Hospitals and Beds by Region, 2005
- Hospital Beds by Department, 2001-2005
- Hospital Activity
- Hospital Activity, 1997-2005
- Hospitalisations by Department, 2001-2005
- Hospital Activity by Department,
- Hospital Admissions by Cause, 2005 (ICD 10)
- Transplants & Cardiosurgeries Performed, 1991-2005
- Kidney Dialysis,
- Hospital Equipment
- Selected Installed Equipment in Hospitals, 2005
- Selected Installed Equipment in Hospitals, 1997-2005
- Ambulatory Care
- Outpatient Facilities, 2001-2005
- Outpatient Examinations in Inpatient & Outpatient Establishments,
- Outpatient Visits, 1998-2004 (000s)
- Medical Personnel
- Total Medical Personnel by Type of Employment, 2005 (Whole-Time Equivalent)
- Total Medical Personnel, 2004-2005
- Total Medical Personnel by Region, 2005
- Physicians by Workplace,
- Physicians by Speciality, 2005
- Charts
- Health Expenditure by Source of Funding, 2005 (%)
- Hospital Beds, 1995-2004
- Hospital Beds, Rate Per Thousand Population, 1995-2005
- Chichester, West Sussex, PO20 2FS, United Kingdom
- Accessing The Pharmaceutical
- Market
Accessing The Pharmaceutical Market
- Introduction
- Regulatory Environment
- The Medicines Act and the Transposition of EU Directives
- Pharmaceutical Registration/Drug Approval Process
- SUKL Drug Registration Activity, 1999-2004
- Clinical trials
- Post marketing surveillance
- New EU Rules
- Centralised procedure
- Mutual recognition procedure
- Advertising
- Patent Protection & Intellectual Property Rights
- Pricing and Reimbursement
- Price margins
- Distribution Channels
- Domestic Production
- GMP Compliance
- API Manufacturers with GMP Certificates, January 2007
- Trade Associations
- MAFS Members, 2007
- CAFF Members,
- Domestic Producers
- Farmak
- Farmak Sales, 2000-2003 (KCs millions)
- ICN Czech Republic (VUAB)
- IVAX CR
- Medicamenta
- Pliva-Lachema
- Spofa
- Zentiva
- Zentiva: Top Brands, 2005 (CZK millions)
- Results for 2005
- Zentiva Financial Results,
- Pharmaceutical Sales by Region, 2004-2005 (CZK millions)
- Directory
- Czech Republic Accessing The Pharmaceutical Market
- Government Bodies
- Trade Associations
|
|
|